|
|
Reference
|
|
  
|
Anaya, J.M., Diethelm, L., Ortiz, L.A., Gutierrez, M., Citera, G., Welsh, R.A., Espinoza, L.R. (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum, 24(4): 242-54
|
|
|
Bestall, J.C., Paul, E.A., Garrod, R., Garnham, R., Jones, P.W., Wedzicha, J.A. (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7): 581-6
|
|
|
Dawson, J.K., Fewins, H.E., Desmond, J., Lynch, M.P., Graham, D.R. (2002) Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis, 61(6): 517-21
|
|
|
Franquet, T. (2004) High resolution computed tomography of the lungs. u: Wlls A.U., Denton C.P. (ur.) Pulmonary involvement in systemic autoimmune diseases, London: Elsevier, p. 25-44
|
|
|
Horton, M.R. (2004) Rheumatoid arthritis associated interstitial lung disease. Crit Rev Comput Tomogr, 45(5-6): 429-40
|
|
1
|
Hunninghake, G.W., Fauci, A.S. (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis, 119(3): 471-503
|
|
|
Lomeo, R.M., Cornella, R.J., Schabel, S.I., Silver, R.M. (1989) Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis. Am J Med, 87(5): 525-7
|
|
|
Minai, O.A., Dweik, R.A., Arroliga, A.C. (1998) Manifestations of scleroderma pulmonary disease. Clin Chest Med, 19(4): 713-31, viii-ix
|
|
1
|
Morelli, S., Barbieri, C., Sgreccia, A., Ferrante, L., Pittoni, V., Conti, F., Gualdi, G., Polettini, E., Carlesimo, O.A., Calvieri, S. (1997) Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol, 24(1): 81-5
|
|
|
Murin, S., Wiedemann, H.P., Matthay, R.A. (1998) Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med, 19(4): 641-65, viii
|
|
2
|
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R.O., Burgos, F., Casaburi, R., i dr. (2005) Interpretative strategies for lung function tests. European Respiratory Journal, 26(5): 948
|
|
|
Steen, V.D., Conte, C., Owens, G.R., Medsger, T.A. (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum, 37(9): 1283-9
|
|
|
Takahashi, H., Kuroki, Y., Tanaka, H., Saito, T., Kurokawa, K., Chiba, H., Sagawa, A., Nagae, H., Abe, S. (2000) Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med, 162(1): 258-63
|
|
|
Warrick, J.H., Bhalla, M., Schabel, S.I., Silver, R.M. (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol, 18(10): 1520-8
|
|
|
Wells, A.U., Hansell, D.M., Rubens, M.B., King, A.D., Cramer, D., Black, C.M., Bois, R.M. (1997) Fibrosing alveolitis in systemic sclerosis: Indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum, 40(7): 1229-36
|
|
|
Yanaba, K., Hasegawa, M., Hamaguchi, Y., Fujimoto, M., Takehara, K., Sato, S. (2003) Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: Association with the activity of pulmonary fibrosis. Clin Exp Rheumatol, 21(4): 429-36
|
|
|
Zisman, D.A., McCune, W.J., Tino, G., Lynch, J.P. (2001) Drug-induced pneumonitis: The role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis, 18(3): 243-52
|
|
|
|
|